Cardiac Resynchronization Therapy Devices Exhibits a Boost

Thursday 6 September 2012, Amsterdam

As per the new report "US Cardiac Device Market Analysis", the US has been witnessing an uprise in the incidences of cardiovascular-related complications and therefore the cardiac medical devices sector is a current industry focus. As the population is getting older, this trend is expected to continue in future also, thereby supporting the prominent growth in the sector. With the total size hovering around US$ 17.5 Bn in 2011, the market is further expected to perform good in coming years also with technological upgradation playing a key role.

We have found that cardiac resynchronization therapy devices is expected to fuel the growth in the US cardiac rhythm management market, which currently is dominated by implantable cardioverter defibrillator (ICD). High incidences of congestive heart failure will boost the cardiac resynchronization therapy sub-segment in future, which contributed around 34% in the 2011 cardiac rhythm management sector.

The report, which is an outcome of an extensive research and in-depth analysis, facilitates the future forecasts on overall US cardiac medical devices market size during 2012-2015. It analyzes the opportunity assessment for companies in the US cardiac medical devices market by providing prudent analysis of competitors' profiling that covers areas like business description, financial overview, strengths & weaknesses and key developments. Overall, the report is meant to provide clients with an optimum source of knowledge and statistics in the US cardiac medical devices sector.